本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

237.35
-4.0300-1.67%
盘后237.350.00000.00%16:57 EST
成交量:53.58万
成交额:1.27亿
市值:146.43亿
市盈率:-53.73
高:240.77
开:238.51
低:234.88
收:241.38
52周最高:248.60
52周最低:124.06
股本:6,169.52万
流通股本:6,008.34万
量比:0.56
换手率:0.89%
股息:- -
股息率:- -
每股收益(TTM):-4.4176
每股收益(LYR):-4.4176
净资产收益率:-818.43%
总资产收益率:-6.86%
市净率:-77.47
市盈率(LYR):-53.73

数据加载中...

2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/11

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities